<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03746886</url>
  </required_header>
  <id_info>
    <org_study_id>Korvike</org_study_id>
    <nct_id>NCT03746886</nct_id>
  </id_info>
  <brief_title>Lipids and Other Bioactive Compounds of Human Breast Milk</brief_title>
  <official_title>Lipids and Other Bioactive Compounds of Human Breast Milk and Infant Formulas.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biochemical differences in the composition of breast milk and formula have not been
      profoundly established in all compound groups. Increased understanding of breast milk
      composition, the normal variation of various bioactive compounds and their levels is required
      to be able to develop formulas better corresponding the breast milk, and ensure the optimal
      development of also the formula-fed babies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relative proportions (%) of regioisomers within selected molecular species (acyl carbon number:number of double bonds 50:1 and 52:2) in triacylglycerols.</measure>
    <time_frame>11/2018-12/2019</time_frame>
    <description>Isolation of lipids from the milk with solvent extraction. Isolation of triacylglycerols with solid phase extraction. Negative ionization of the triacylglycerols with ammonia. Selection of the molecular weight species in the first quadruple of the MS/MS. Fragmentation of the selected ions with argon. Separation of the fragment ions in the second quadrupole of the MS/MS. Calculation of the relative proportions of regioisomers with a computer software.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative proportions (%) of fatty acids in triacylglycerols of human milk.</measure>
    <time_frame>11/2018-12/2019</time_frame>
    <description>Isolation of lipids from the milk with solvent extraction. Isolation of triacylglycerols with solid phase extraction. Quantitation with gas chromatograph coupled with flame ionization detector in relation to external standards.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantity (mg/ml) of lipid soluble compounds in triacylglycerols of human milk.</measure>
    <time_frame>11/2018-12/2019</time_frame>
    <description>Isolation of lipids from the milk with solvent extraction. Gravimetric analysis of the lipids.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Breast Milk Collection</condition>
  <arm_group>
    <arm_group_label>Breast-feeding women</arm_group_label>
    <description>A single breast-milk sample will be collected from 20 women who breast-feed their child (0-6 months old).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Breast-milk</intervention_name>
    <description>A single breast-milk sample will be collected from 20 women. Milk samples will be pooled for analysis.</description>
    <arm_group_label>Breast-feeding women</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Human breast-milk samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        18-45 years old women who breast-feed their 0-6 months old child
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  breast-fed child was born full-time and is healthy.

          -  age of the breast-fed child is 0-6 months

        Exclusion Criteria:

          -  breast-fed child was born prematurely (gestation week &lt;37)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Self-representation</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kaisa M Linderborg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Turku</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaisa M Linderborg, PhD</last_name>
    <phone>+358 2 333 6872</phone>
    <email>kaisa.linderborg@utu.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Biochemistry, University of Turku</name>
      <address>
        <city>Turku</city>
        <zip>20014</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaisa M Linderborg, PhD</last_name>
      <phone>+358 2 333 6872</phone>
      <email>kaisa.linderborg@utu.fi</email>
    </contact>
    <investigator>
      <last_name>Kaisa M Linderborg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>November 7, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turku</investigator_affiliation>
    <investigator_full_name>Kaisa Linderborg</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>breast milk</keyword>
  <keyword>lipids</keyword>
  <keyword>bioactive compounds</keyword>
  <keyword>infant formula</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

